Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $309.8700 (2.42%) ($304.8800 - $314.2900) on Tue. May. 21, 2019. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.07% (three month average) | | RSI | 31 | | Latest Price | $309.8700(2.42%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.4% a day on average for past five trading days. | | Weekly Trend | REGN declines -4.5% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(58%) XLV(48%) IVW(41%) IWF(40%) QQQ(40%) | | Factors Impacting REGN price | REGN will decline at least -1.035% in a week (0% probabilities).
VXX(-11%) TLT(-6%) IFRA(-6%) TIP(-1%) IGOV(0%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.035% (StdDev 2.07%) | | Hourly BBV | 0 () | | Intraday Trend | 1.6% | | | | | |
|
| Resistance Level | $324.49 | | 5 Day Moving Average | $306.25(1.18%) | | 10 Day Moving Average | $310.3(-0.14%) | | 20 Day Moving Average | $324.49(-4.51%) | | To recent high | -29.5% | | To recent low | 2.4% | | Market Cap | $32.855b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |